← back to search

Raquel Yotti

Centro de Investigación Biomédica en Red · ES
Area of research
Cardiology and Cardiovascular Medicine · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics, Cardiomyopathy and Myosin Studies, and Cardiac Valve Diseases and Treatments.
h-index
35
citations
7,617
works
163
NIH funding
primary concept
Medicine
email

Recent publications

Transvalvular jet velocity, aortic valve area, mortality, and cardiovascular outcomes.
2022cited by 15position: contributordoi
Evolution of antibodies against SARS-CoV-2 over seven months: Experience of the nationwide seroprevalence ENE-COVID study in Spain
Journal of Clinical Virology 2022cited by 5position: contributordoi
Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure
JAMA Cardiology 2021cited by 70position: middledoi
Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure.
2021cited by 49position: contributordoi
Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long-Term Survival.
2021cited by 25position: contributordoi
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.
2021cited by 23position: contributordoi
Founder mutation in myosin-binding protein C with an early onset and a high penetrance in males.
2021cited by 13position: contributordoi
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry.
2021cited by 11position: contributordoi
Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry.
2021cited by 11position: contributordoi
ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19.
2021cited by 9position: contributordoi
The impact of Mediterranean diet on coronary plaque vulnerability, microvascular function, inflammation and microbiome after an acute coronary syndrome: study protocol for the MEDIMACS randomized, controlled, mechanistic clinical trial.
2021cited by 9position: contributordoi
Evolution of antibodies against SARS-CoV-2 over seven months: experience of the Nationwide Seroprevalence ENE-COVID Study in Spain
2021cited by 4position: contributordoi
Two Pandemics, Two Surveys in the United States and in Spain.
2021cited by 3position: contributordoi
The impact of Mediterranean diet on coronary plaque vulnerability, microvascular function, inflammation, and microbiome after an acute coronary syndrome: study protocol for the MEDIMACS randomized, controlled, mechanistic clinical trial.
2021cited by 0position: contributordoi
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
The Lancet 2020cited by 1,886position: middledoi
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
2020cited by 1,310position: contributordoi
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.
2020cited by 141position: contributordoi
Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites.
2020cited by 63position: contributordoi
Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants
American Heart Journal 2020cited by 49position: middledoi
Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants.
2020cited by 34position: contributordoi
Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the non-institutionalized population of Spain
2020cited by 9position: contributordoi
SARS-CoV-2 seroprevalence in Spain - Authors' reply.
2020cited by 6position: contributordoi
Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies
Annual Review of Genomics and Human Genetics 2019cited by 173position: firstdoi
Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies.
2019cited by 142position: contributordoi
Familial clustering of bicuspid aortic valve and its relationship with aortic dilation in first-degree relatives.
2019cited by 60position: contributordoi
The Biological Bases of Group 2 Pulmonary Hypertension.
2019cited by 22position: contributordoi
Age-Dependence of Flow Homeostasis in the Left Ventricle.
2019cited by 16position: contributordoi
Valve area and the risk of overestimating aortic stenosis.
2019cited by 16position: contributordoi
The natural matching of harmonic responses in the pulmonary circulation.
2019cited by 3position: contributordoi
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies
European Heart Journal 2018cited by 141position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Francisco Fernández‐Avilés · Universidad Complutense de Madrid8 papers (2013–2021)Beatriz Pérez-Gómez · GEICAM – Spanish Breast Cancer Group7 papers (2020–2022)Javier Bermejo · Universidad Complutense de Madrid6 papers (2013–2017)Israel Cruz · Instituto de Salud Carlos III6 papers (2020–2022)Marina Pollán · Siemens Healthcare (United States)5 papers (2020–2021) · 5 papers (2013–2015)Juan C. del Álamo · University of Washington4 papers (2013–2015)Pablo Martínez‐Legazpi · Instituto de Salud Carlos III4 papers (2014–2015) · 4 papers (2020–2021) · 4 papers (2014–2015)José F. Rodríguez‐Palomares · Instituto de Investigación de Enfermedades Raras3 papers (2019–2021) · 3 papers (2020–2021)Roberto Pastor-Barriuso · Agencia Estatal de Investigación3 papers (2020–2021) · 3 papers (2020–2021)Christine E. Seidman · Harvard University3 papers (2019–2020)Ana González‐Mansilla · Georgetown University3 papers (2014–2015) · 3 papers (2014–2015)Germán Bou · Universidade da Coruña2 papers (2020–2020)Miguel A. Hernán · Harvard University2 papers (2020–2021) · 2 papers (2019–2021)